IP Library › Assignment 035812/0424
Patent Assignment
Reel/Frame 035812/0424

Assignment of Assignor's Interest

Recorded: 2015-06-03 Pages: 27
Assignor
NOVARTIS PHARMA AG
Executed: 2015-03-02
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Properties (80)
9-Beta-D-Arabinofuranasyl-2-Amino-6-Methoxy-9H-Purine
Patent: 5,424,295 →
Application: 08/110,487 →
Treatment of Ovarian Cancer
Patent: 5,674,872 →
Application: 08/411,056 →
Tumor Treatment with Arabinofuranosyl Purine Derivatives
Patent: 5,821,236 →
Application: 08/449,078 →
Therapeutic Methods for Using Ara-G Derivatives
Patent: 5,747,472 →
Application: 08/456,186 →
Suppository Compositions Containing Ondansetron Dihydrate
Patent: 5,741,806 →
Application: 08/537,950 →
Oral Compositions Containing Ondansetron
Patent: 5,854,270 →
Application: 08/817,831 →
Freeze-Dried Compositions
Patent: 5,955,488 →
Application: 09/066,762 →
Ondansetron Freeze-Dried Dosage Form Compositions for Oral Administration
Patent: 6,063,802 →
Application: 09/238,165 →
Novel Metal Complexes
Patent: 6,280,959 →
Application: 09/530,307 →
Publication: US 2001/0014454
Thrombopoietin Mimetics
Patent: 7,160,870 →
Application: 10/296,688 →
Publication: US 2004/0019190
3'-[(2Z)-[1-(3,4-Dimethylphenyl)-1,5-Dihydro-3-Methyl-5-Oxo-4H-Pyrazol-4-Ylidene]Hy-Drazino]-2'-Hydroxy-[1,1'-Biphenyl]-3-Carboxylic Acid Bis-(Monoethanolamine)
Patent: 7,547,719 →
Application: 10/515,304 →
Publication: US 2006/0178518
Crystalline Topotecan Hydorchloride Product and Process for Making the Same
Patent: 7,754,733 →
Application: 10/578,660 →
Publication: US 2007/0117832
Thrombopoietin Mimetics
Patent: 7,335,649 →
Application: 11/558,071 →
Publication: US 2007/0179192
Thrombopoietin Mimetics
Patent: 7,332,481 →
Application: 11/620,260 →
Publication: US 2007/0129338
Thrombopoietin Mimetics
Patent: 7,473,686 →
Application: 11/650,651 →
Publication: US 2008/0214640
Thrombopoietin Mimetics
Patent: 7,439,342 →
Application: 11/650,688 →
Publication: US 2008/0090996
Thrombopoietin Mimetics
Patent: 7,452,874 →
Application: 11/650,838 →
Publication: US 2008/0090787
Inhibitors of Akt Activity
Patent: 8,273,782 →
Application: 12/027,454 →
Publication: US 2009/0209607
Thrombopoietin Mimetics
Patent: 7,674,887 →
Application: 12/141,379 →
Publication: US 2009/0176973
Thrombopoietin Mimetics
Patent: 7,790,704 →
Application: 12/141,397 →
Publication: US 2009/0155203
Thrombopoietin Mimetics
Patent: 7,648,971 →
Application: 12/141,422 →
Publication: US 2009/0176746
Benzene Sulfonamide Thiazole and Oxazole Compounds
Patent: 7,994,185 →
Application: 12/434,963 →
Publication: US 2009/0298815
3'-[(2Z)-[1-(3,4-Dimethylphenyl)-1,5-Dihydro-3-Methyl-5-Oxo-4H-Pyrazol-4-Ylidene]Hydrazino]-2'-Hydroxy-[1,1'-Biphenyl]-3-Carboxylic Acid Bis-(Monoethanolamine)
Patent: 7,795,293 →
Application: 12/472,819 →
Publication: US 2009/0291995
Inhibitors of Akt Activity
Patent: 8,410,158 →
Application: 12/526,111 →
Publication: US 2010/0267759
3'-[(2Z)-[1-(3,4-Dimethylphenyl)-1,5-Dihydro-3-Methyl-5-Oxo-4H-Pyrazol-4-Ylidene]Hydrazino]-2'-Hydroxy-[1,1'-Biphenyl]-3-Carboxylic Acid Bis-(Monoethanolamine)
Patent: 8,071,129 →
Application: 12/607,284 →
Publication: US 2010/0040683
3'-[(2Z)-[1-(3,4-Dimethylphenyl)-1,5-Dihydro-3-Methyl-5-Oxo-4H-Pyrazol-4-Ylidene]Hydrazino]-2'-Hydroxy-[1,1'-Biphenyl]-3-Carboxylic Acid Bis-(Monoethanolamine)
Patent: 8,052,993 →
Application: 12/607,291 →
Publication: US 2010/0040684
3'-[(2Z)-[1-(3,4-Dimethylphenyl)-1,5-Dihydro-3-Methyl-5-Oxo-4H-Pyrazol-4-Ylidene]Hydrazino]-2'-Hydroxy-[1,1'-Biphenyl]-3-Carboxylic Acid Bis-(Monoethanolamine)
Patent: 8,052,994 →
Application: 12/607,305 →
Publication: US 2010/0047346
3'-[(2Z)-[1-(3,4-Dimethylphenyl)-1,5-Dihydro-3-Methyl-5-Oxo-4H-Pyrazol-4-Ylidene]Hydrazino]-2'-Hydroxy-[1,1'-Biphenyl]-3-Carboxylic Acid Bis-(Monoethanolamine)
Patent: 8,062,665 →
Application: 12/607,320 →
Publication: US 2010/0047347
3'-[(2Z)-[1-(3,4-Dimethylphenyl)-1,5-Dihydro-3-Methyl-5-Oxo-4H-Pyrazol-4-Ylidene]Hydrazino]-2'-Hydroxy-[1,1'-Biphenyl]-3-Carboxylic Acid Bis-(Monoethanolamine)
Patent: 8,052,995 →
Application: 12/607,330 →
Publication: US 2010/0047348
Antibody Formulations
Application: 12/667,890 →
Publication: US 2011/0020328
Crystalline N-{(1S)-2-Amino-1-[(3-Fluorophenyl)Methyl]Ethyl}-5-Chloro-4-(4-Chloro-1-Methyl-1H-Pyrazol-5-Yl)-2-Thiophenecarboxamide Hydrochloride
Patent: 8,609,711 →
Application: 12/695,331 →
Publication: US 2010/0197754
Novel Compound, Corresponding Compositions, Preparation and/or Treatment Methods
Patent: 8,158,645 →
Application: 12/770,898 →
Publication: US 2010/0210677
3'-[(2Z)-[1-(3,4-Dimethylphenyl)-1,5-Dihydro-3-Methyl-5-Oxo-4H-Pyrazol-4-Ylidene]Hydrazino]-2'-Hydroxy-[1,1'-Biphenyl]-3-Carboxylic Acid Bis-(Monoethanolamine)
Patent: 8,088,813 →
Application: 12/873,565 →
Publication: US 2011/0081312
Benzene Sulfonamide Thiazole and Oxazole Compounds
Patent: 8,415,345 →
Application: 12/991,004 →
Publication: US 2011/0172215
3'-[(2Z)-[1-(3,4-Dimethylphenyl)-1,5-Dihydro-3-Methyl-5-Oxo-4H-Pyrazol-4-Ylidene]Hydrazino]-2'-Hydroxy-[1,1'-Biphenyl]-3-Carboxylic Acid Bis-(Monoethanolamine)
Patent: 8,828,430 →
Application: 13/272,367 →
Publication: US 2012/0093927
Method of Treating Thrombocytopenia
Patent: 8,476,249 →
Application: 13/318,550 →
Publication: US 2012/0052055
Methods of Administration of Thrombopoietin Agonist Compounds
Patent: 8,609,693 →
Application: 13/321,577 →
Publication: US 2012/0064036
Novel Pharmaceutical Composition
Patent: 8,580,304 →
Application: 13/330,949 →
Publication: US 2012/0183613
Combination
Application: 13/368,434 →
Publication: US 2012/0258933
A Non-Peptide Thrombopoietin Receptor Agonist in the Treatment of Cancer and Pre-Cancerous Syndromes
Patent: 8,637,563 →
Application: 13/487,512 →
Publication: US 2012/0295918
Pharmaceutical Combination of MEK Inhibitor and B-RAF Inhibitors
Patent: 8,703,781 →
Application: 13/499,779 →
Publication: US 2012/0196879
Combination
Patent: 8,835,450 →
Application: 13/500,241 →
Publication: US 2012/0196886
Combination
Patent: 8,796,298 →
Application: 13/500,698 →
Publication: US 2012/0202835
Combination
Application: 13/501,387 →
Publication: US 2012/0202822
Thrombopoietin Mimetics
Application: 13/593,739 →
Publication: US 2013/0078213
Combination of Lapatinib and Trametinib
Patent: 9,180,129 →
Application: 13/699,077 →
Publication: US 2013/0109705
Benzene Sulfonamide Thiazole and Oxazole Compounds
Patent: 8,642,759 →
Application: 13/755,466 →
Publication: US 2013/0144055
INHIBITORS OF AkT ACTIVITY
Patent: 8,946,278 →
Application: 13/774,022 →
Publication: US 2013/0231378
Combination of BRAF and VEGF Inhibitors
Application: 13/820,834 →
Publication: US 2013/0172378
Methods for Treating Cancer
Application: 13/883,374 →
Publication: US 2013/0217710
Novel Uses
Application: 13/978,723 →
Publication: US 2013/0315901
Combination
Application: 13/978,765 →
Publication: US 2013/0288984
Combination for the Treatment of Cancer
Patent: 8,906,879 →
Application: 13/991,576 →
Publication: US 2013/0261075
Novel Pharmaceutical Composition
Patent: 9,271,941 →
Application: 14/044,139 →
Publication: US 2014/0037726
3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID bis-(MONOETHANOLAMINE)
Patent: 8,846,024 →
Application: 14/050,976 →
Publication: US 2014/0037580
Benzene Sulfonamide Thiazole and Oxazole Compounds
Patent: 9,233,956 →
Application: 14/088,598 →
Publication: US 2014/0080851
Methods for Treating Degenerative Diseases/Injuries
Application: 14/100,560 →
Publication: US 2014/0100258
Novel Pharmaceutical Composition
Patent: 9,399,021 →
Application: 14/103,092 →
Publication: US 2014/0154316
Novel Pharmaceutical Composition
Patent: 9,155,706 →
Application: 14/103,193 →
Publication: US 2014/0099365
Method of Treating Thrombocytopenia
Application: 14/150,112 →
Publication: US 2014/0142155
Pharmaceutical Combination of Mek Inhibitor and B-Raf Inhibitors
Patent: 8,952,018 →
Application: 14/197,421 →
Publication: US 2014/0187566
Combination
Application: 14/270,774 →
Publication: US 2015/0094321
Cancer Treatment Method
Application: 14/291,667 →
Publication: US 2014/0275107
Methods for Treating Degenerative Diseases/Injuries
Application: 14/293,209 →
Publication: US 2014/0275193
Combination
Application: 14/309,262 →
Publication: US 2014/0303195
Combination
Application: 14/317,775 →
Publication: US 2014/0309243
Pharmaceutical Combination of a VEGFR Inhibitor and a MEK Inhibitor for Treating Cancer
Application: 14/327,660 →
Publication: US 2014/0323506
Treatment Method for Steroid Responsive Dermatoses
Application: 14/394,394 →
Publication: US 2015/0087683
Method of Adjuvant Cancer Treatment
Application: 14/422,182 →
Publication: US 2015/0216868
3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
Application: 14/450,569 →
Publication: US 2014/0341991
Combination of Inhibitor of B-Raf and an Inhibitor of Akt in the Treatment of Cancer
Patent: 9,402,846 →
Application: 14/456,180 →
Publication: US 2014/0350039
3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID bis-(MONOETHANOLAMINE)
Application: 14/478,134 →
Publication: US 2015/0079030
CRYSTALLINE N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
Application: 14/521,593 →
Publication: US 2015/0045405
Combination
Application: 14/543,126 →
Publication: US 2015/0073002
INHIBITORS OF Akt ACTIVITY
Application: 14/562,968 →
Publication: US 2015/0152092
Combination
Application: 14/565,691 →
Publication: US 2015/0094283
Thrombopoietin Mimetics
Application: 14/567,277 →
Publication: US 2015/0093356
Pharmaceutical Combination of Mek Inhibitor and B-Raf Inhibitors
Application: 14/578,804 →
Publication: US 2015/0111904
Combination
Application: 14/590,143 →
Publication: US 2015/0119337
Antibody Formulations
Application: 14/625,881 →
Publication: US 2015/0158951
Related Assignments (19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 26, 2007
From: GLAXO GROUP LIMITED
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 019605/0677 →
Assignment of Assignor's Interest Jun 22, 2009
From: DELL'ORCO, PHILIP C.; DIEDERICH, ANN MARIE; SU, QIAOGONG; WOOD, JEFFERY LEE
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 022853/0079 →
Assignment of Assignor's Interest Aug 13, 2009
From: GLAXO GROUP LIMITED
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 023096/0656 →
Change of Name Dec 15, 2009
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 023649/0370 →
Change of Name Jan 6, 2010
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 023731/0744 →
Change of Name Jan 6, 2010
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 023731/0766 →
Change of Name Jan 15, 2010
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 023794/0158 →
Change of Name Jan 15, 2010
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 023794/0337 →
Change of Name Jan 29, 2010
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 023869/0366 →
Assignment of Assignor's Interest Jan 11, 2012
From: SEEFELD, MARK ANDREW; ROUSE, MEAGAN B; HEERDING, DIRK A
To: GLAXOSMITHKLINE LLC
Reel/Frame 027515/0713 →
Change of Name Oct 16, 2014
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 034009/0663 →
Assignment of Assignor's Interest Nov 25, 2014
From: WINTERBORN, IAN KEITH
To: GLAXO WELLCOME INC.
Reel/Frame 034470/0980 →
Merger Nov 25, 2014
From: GLAXO WELLCOME INC
To: GLAXOSMITHKLINE INC
Reel/Frame 034471/0026 →
Merger and Change of Name Feb 19, 2015
From: LABORATOIRE GLAXO WELLCOME SA; LABORATOIRE GLAXOSMITHKLINE S A S
To: LABORATOIRE GLAXOSMITHKLINE S A S
Reel/Frame 035070/0817 →
Assignment of Assignor's Interest Jun 2, 2015
From: GLAXOSMITHKLINE LLC
To: NOVARTIS PHARMA AG
Reel/Frame 035806/0473 →
Assignment of Assignor's Interest Jun 2, 2015
From: GLAXOSMITHKLINE LLC
To: GLAXO GROUP LIMITED
Reel/Frame 035806/0320 →
Assignment of Assignor's Interest Jun 2, 2015
From: GLAXOSMITHKLINE INC.
To: NOVARTIS PHARMA AG
Reel/Frame 035805/0723 →
Assignment of Assignor's Interest Jun 2, 2015
From: LABORATOIRE GLAXOSMITHKLINE
To: NOVARTIS PHARMA AG
Reel/Frame 035806/0740 →
Assignment of Assignor's Interest Jun 2, 2015
From: GLAXO GROUP LIMITED
To: NOVARTIS PHARMA AG
Reel/Frame 035806/0563 →